New fund to help med-tech startups in Singapore
The Singapore Government has launched a new initiative to encourage medical technology startups, offering a S$40 million (US$32.6 million) fund under the Biomedical Science Accelerator (BSA) Program.
Singapore’s entrepreneurship promoter SPRING Singapore said its investment unit SPRING SEEDS Capital will manage the program, identifying ‘high-potential med-tech startups’, investing in them on a one-to-one basis and assisting the sector to better commercialize the intellectual property it develops.
Biotech is a key contributor to Singapore’s economy, consisting of 10% of Singapore’s manufacturing output and employing 13,000 people. The BSA program acknowledges that startups in the field often struggle with its knowledge and capital intensive nature, and aims to help those with innovative ideas succeed.
source & article: Today Online
- Biotech entrepreneurship flourishing in Malaysia
- World Bank Group to open office in Singapore
- ‘Wave’ of FDI flows into Malaysia in 2011
- The Economist: good policies creating a strong Penang
- Senai Hi-Tech Park will help transform Malaysia, says PM Najib
- Could Indonesia overtake Thailand as an auto manufacturer?
- Indonesia to give tax holidays to major foreign investors
- Singapore tightens conditions for foreign workers
- US$4.7bn in major gas projects approved for Indonesia
- Singapore may benefit from financial gloom: survey